These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 13764571)

  • 21. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.
    Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR
    Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996
    [No Abstract]   [Full Text] [Related]  

  • 22. [Familial hypercholesterolemia: clinical aspects].
    Ciarrocchi A; Gaddi A; Rimondi S; Mezzetti M; Scaramuzzino G
    Cardiologia; 1988 Nov; 33(11):1055-60. PubMed ID: 3255492
    [No Abstract]   [Full Text] [Related]  

  • 23. Early development of xanthoma and coronary disease in a young female with homozygous familial hypercholesterolemia.
    Zhao X; Bu L; Qin S; Kong D; Fan B; Ge J
    Int J Cardiol; 2014 Sep; 176(1):e15-9. PubMed ID: 25043216
    [No Abstract]   [Full Text] [Related]  

  • 24. Familial defective apolipoprotein B-100: a lesson from homozygous and heterozygous patients.
    Ceska R; Vrablík M; Horínek A
    Physiol Res; 2000; 49 Suppl 1():S125-30. PubMed ID: 10984082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia.
    Real JT; Chaves FJ; Martínez-Usó I; García-García AB; Ascaso JF; Carmena R
    Eur Heart J; 2001 Mar; 22(6):465-71. PubMed ID: 11237541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
    deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
    Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Next generation sequencing to identify novel genetic variants causative of autosomal dominant familial hypercholesterolemia associated with increased risk of coronary heart disease.
    Al-Allaf FA; Athar M; Abduljaleel Z; Taher MM; Khan W; Ba-Hammam FA; Abalkhail H; Alashwal A
    Gene; 2015 Jul; 565(1):76-84. PubMed ID: 25839937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of high risk relatives for coronary heart disease.
    Schieken RM
    J Am Coll Cardiol; 1988 Oct; 12(4):1110-3. PubMed ID: 2971084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Findings or disease--lipid metabolism with reference to the heart].
    Wolfram G
    Internist (Berl); 1986 Mar; 27(3):158-65. PubMed ID: 3519502
    [No Abstract]   [Full Text] [Related]  

  • 30. Familial hypercholesterolemia: mechanism of inheritance.
    de Oya M; Nuno J; Azpeitia AG; Villasante JG
    Diabete Metab; 1980 Sep; 6(3):181-8. PubMed ID: 7439491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The HGAR1 familial hypercholesterolemia pedigree.
    Bailey-Wilson JE; Elston RC
    Genet Epidemiol; 1993; 10(6):529-31. PubMed ID: 8314055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of mutations and genetherapy. Clinical genetics of familial hypercholesterolemia.
    Schuster H
    Z Gastroenterol; 1996 Jun; 34 Suppl 3():4-5. PubMed ID: 8767443
    [No Abstract]   [Full Text] [Related]  

  • 33. Coronary artery bypass grafting in familial hypercholesterolemia.
    Kawasuji M; Sakakibara N; Takemura H; Matsumoto Y; Mabuchi H; Watanabe Y
    J Thorac Cardiovasc Surg; 1995 Feb; 109(2):364-9. PubMed ID: 7853888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lipid content of the blood serum in relatives of patients with ischemic heart disease].
    Koshechkin VA; Titov VN; Deev AD
    Kardiologiia; 1976 Feb; 16(2):60-4. PubMed ID: 966445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma Lp(a) values in familial hypercholesterolemia and its relation to coronary heart disease.
    Real JT; Ascaso JF; Chaves FJ; Tenés S; Priego MA; Puig O; Armengod ME; Carmena R
    Nutr Metab Cardiovasc Dis; 1999 Feb; 9(1):41-4. PubMed ID: 10726108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aggressive lipid lowering treatment in coronary atherosclerosis.
    Stalenhoef AF; Kroon AA; Aengevaeren WR
    Cardiologia; 1997 Sep; 42(9):935-40. PubMed ID: 9369038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular genetics of cholesterol transport and cholesterol reverse transport disorders (familial hypercholesterolemia and CETP deficiency), and coronary heart disease].
    Mabuchi H
    Rinsho Byori; 1995 Apr; 43(4):342-6. PubMed ID: 7739114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [JUVENILE CORONARY DISEASE DURING FAMILIAL XANTHOMATOUS HYPERCHOLESTEREMIA].
    KHOURI RM
    Rev Atheroscler; 1964; 6():83-6. PubMed ID: 14223340
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinico-genealogical characteristics of patients with ischemic heart disease and different disorders of lipid metabolism].
    Chernyshov VA; Tseluĭko VI
    Kardiologiia; 1992 Mar; 32(3):13-7. PubMed ID: 1405202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LDL-apheresis: clinical experience and indications in the treatment of severe hypercholesterolemia.
    Thiery J; Seidel D
    Transfus Sci; 1993 Jul; 14(3):249-59. PubMed ID: 10146336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.